Cancer Research Malaysia entered into a Memorandum of Understanding with the Global Institute For Tomorrow (GIFT) to support the FWD Leading Edge Development Programme held in Malaysia from 9-13 June 2025.
Through this collaboration, a global cohort of international business leaders participated in a strategic advisory programme to develop business recommendations for Cancer Research Malaysia initiatives, including MeMoSA®. The programme provided an opportunity for participants to analyse real-world challenges and propose strategies to strengthen the scalability and sustainability of CRMY’s innovations.
As part of the programme, participants visited Kampung Orang Asli Serendah to gain first-hand insight into the healthcare challenges faced by underserved communities, helping inform discussions on how technologies such as MeMoSA® can improve access to early detection services.
The programme concluded with the delivery of strategic business recommendations to support the future scaling of MeMoSA® initiatives.